Public Health Alert: Measles Outbreak

Australian Medical Association

The Queensland Public Health and Scientific Services, Communicable Diseases Branch shared a public health alert on Friday 13 December 2024 regarding measles outbreaks.

The Queensland Public Health and Scientific Services, Communicable Diseases Branch shared the below public health alert on Friday 13 December 2024 regarding measles outbreaks.


Key points

  1. measles outbreaks are occurring in a number of overseas countries, with cases notified in travellers to Victoria, Western Australia and Queensland
  2. there have been two cases of measles in returning overseas travellers to Queensland in recent weeks. Further cases may present in Queensland
  3. clinicians should be alert for signs and symptoms of measles, particularly in travellers or those potentially exposed to measles
  4. suspected cases should be tested, advised to isolate, and notified to the local public health unit

THINK measles in patients who present with:

  • generalised maculopapular rash (usually begins on the face, before spreading to the rest of the body) AND
  • fever (usually at least 38oC) present at rash onset AND
  • cough or conjunctivitis or koplik spots

Who is most at risk?

  • infants under 12 months who are too young to be vaccinated against measles, other members of the community who are not fully vaccinated and people with a weakened immune system

Management

  • test for measles and isolate patient
  • advise patients to call the pathology service prior to presenting
  • notify the local Public Health Unit immediately on clinical suspicion to allow timely follow up of high risk contacts
  • non-immune people who have been exposed to measles should receive an MMR vaccine (or MMRV in some instances) for post-exposure prophylaxis, ideally within 72 hours of exposure.
  • MMR-containing vaccines are contraindicated in pregnant women. Normal human immunoglobulin (NHIG) may be recommended by public health authorities.

Measles transmission can occur in healthcare settings.

When a patient with suspected measles attends a healthcare facility, contacts (other patients/staff at the facility) are at risk of acquiring the infection.

The following recommendations will minimise the risk of transmission within facilities:

  • avoid keeping patients with fever and rash in shared waiting areas. Consider how the patient may be examined in an area that minimises exposure to others
  • ensure the patient is wearing a surgical mask
  • staff to use airborne transmission-based precautions for all patient care
  • leave all rooms that were used to assess the patient vacant for at least 30 minutes afterwards
  • ensure all staff in contact with the patient are fully vaccinated (2 documented doses of measles containing vaccine) or have serologically confirmed immunity to measles
  • contact your local public health unit or your facility Infection Prevention and Control team for further advice

Prevention

  • anyone born during or since 1966 are recommended to have two documented doses of measles containing vaccine four weeks apart
  • travellers who are not immune or are unsure of their vaccination history should be vaccinated before they leave Australia. Consider an individual risk assessment for infants aged <12 months
  • there is no need to check measles serology prior to vaccination

Further information

/AMA/AusMed News. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).